Business Description
RedHill Biopharma is an Israeli pharmaceutical company founded in 2009 and based in Tel Aviv, with a focus on treating digestive and infectious conditions. It currently sells two approved medicines: Talicia, which targets H. pylori bacterial infections, and Aemcolo, designed for travelers who develop diarrhea. Beyond these products, the company is advancing a pipeline of five drug candidates targeting a range of conditions, including COVID-19, Crohn's disease, bowel disorders, and a serious lung infection caused by Mycobacterium avium complex.
